Search research articles
Contact Us
Filters
Showing results (1-10 of 106) with videos related to
Page
of 11
Sort By:
Pediatrics in Review
|
January 2, 2009
Hematopoietic growth factors in pediatric patients
Peter D Cole
Future Oncology (London, England)
|
July 11, 2015
Does genetic susceptibility increase risk for neurocognitive decline among patients with acute lymphoblastic leukemia?
Peter D Cole
Pediatric Blood & Cancer
|
June 24, 2020
Safety of limited therapeutic monitoring after high-dose methotrexate in developing countries
Lisa Gennarini, Peter D Cole
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 22, 2021
Biomarkers of Cognitive Impairment in Pediatric Cancer Survivors
AnnaLynn M Williams, Peter D Cole
Journal of Pediatric Hematology/Oncology
|
December 10, 2003
"Beriberi" interesting!
Peter D Cole, Barton A Kamen
Blood
|
May 8, 2010
Successful treatment using omacetaxine for a patient with CML and BCR-ABL1 [corrected] 35INS
Kris M Mahadeo, Peter D Cole
Current Hematologic Malignancy Reports
|
March 21, 2017
Pharmacogenetic Predictors of Treatment-Related Toxicity Among Children With Acute Lymphoblastic Leukemia
Rochelle R Maxwell, Peter D Cole
Mental Retardation and Developmental Disabilities Research Reviews
|
October 25, 2006
Delayed neurotoxicity associated with therapy for children with acute lymphoblastic leukemia
Peter D Cole, Barton A Kamen
Cancer Nursing
|
February 2, 2023
Race, Neighborhood Opportunity, and Life-Threatening Complications in Children With Cancer: A Moderated Mediation Approach
Beth Savage, Peter D Cole, Haiqun Lin
Journal of Pediatric Oncology Nursing : Official Journal of the Association of Pediatric Oncology Nurses
|
May 5, 2021
Racial and Economic Differences in the Risk of Hyperglycemia in Children Hospitalized With Acute Lymphoblastic Leukemia
Beth Savage, Peter D Cole, Haiqun Lin
Page
of 11
Search research articles
Search
Showing results (1-10 of 106) with videos related to
Sort By:
Page
of 11
Pediatrics in Review
|
January 2, 2009
Hematopoietic growth factors in pediatric patients
Peter D Cole
Future Oncology (London, England)
|
July 11, 2015
Does genetic susceptibility increase risk for neurocognitive decline among patients with acute lymphoblastic leukemia?
Peter D Cole
Pediatric Blood & Cancer
|
June 24, 2020
Safety of limited therapeutic monitoring after high-dose methotrexate in developing countries
Lisa Gennarini, Peter D Cole
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 22, 2021
Biomarkers of Cognitive Impairment in Pediatric Cancer Survivors
AnnaLynn M Williams, Peter D Cole
Journal of Pediatric Hematology/Oncology
|
December 10, 2003
"Beriberi" interesting!
Peter D Cole, Barton A Kamen
Blood
|
May 8, 2010
Successful treatment using omacetaxine for a patient with CML and BCR-ABL1 [corrected] 35INS
Kris M Mahadeo, Peter D Cole
Current Hematologic Malignancy Reports
|
March 21, 2017
Pharmacogenetic Predictors of Treatment-Related Toxicity Among Children With Acute Lymphoblastic Leukemia
Rochelle R Maxwell, Peter D Cole
Mental Retardation and Developmental Disabilities Research Reviews
|
October 25, 2006
Delayed neurotoxicity associated with therapy for children with acute lymphoblastic leukemia
Peter D Cole, Barton A Kamen
Cancer Nursing
|
February 2, 2023
Race, Neighborhood Opportunity, and Life-Threatening Complications in Children With Cancer: A Moderated Mediation Approach
Beth Savage, Peter D Cole, Haiqun Lin
Journal of Pediatric Oncology Nursing : Official Journal of the Association of Pediatric Oncology Nurses
|
May 5, 2021
Racial and Economic Differences in the Risk of Hyperglycemia in Children Hospitalized With Acute Lymphoblastic Leukemia
Beth Savage, Peter D Cole, Haiqun Lin
Page
of 11